Virtual Symposium:
Oligonucleotides: Chemistry & Therapeutics
28 April 2021 | BST (UTC+1)
An intensive 1-day meeting that delves into the latest developments in oligonucleotide synthesis, chemistry, process & analytical development, and therapeutics
The programme brings together world leaders from international pharmaceutical organisations and leading academic institutions to discuss the latest in Oligonucleotides
Download Agenda
Full details on the symposium, including the presentations, topic areas and confirmed speakers can be found in the conference brochure
Book Online
Registration for Virtual Symposium: Oligonucleotides: Chemistry & Therapeutics is now open. Please click the button below to register your interest.
LinkedIn Group

Our LinkedIn group aims to foster discussion and collaboration between experts working in proteins, bispecifics, peptides and oligonucleotides

Virtual Symposium:
CTCs & Liquid Biopsies

is sponsored by


The Virtual Symposium: Oligonucleotides: Chemistry & Therapeutics includes...

Attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions working within Oligonucleotides

  • Hear from and meet with the leading figures in oligonucleotide chemistry, analytical development, and therapeutics; offering in-depth presentations and new ideas you can use to advance your research
  • Gain insights into the latest innovation in oligo analytical methods, purification technology development, delivery methods of oligos and advanced synthesis techniques
  • Interact with speakers during the live Q&As, taking place at the end of each presentation and participate in our interactive panel discussions focusing on key challenges & market opportunities
  • Explore case studies pertaining to how oligonucleotides are used in therapeutics through looking at specific areas such as advancements in oligo therapeutics for oncology, genetic disorders, infectious diseases as well as miRNA therapeutics

Agenda at a Glance

Morning Session: Synthesis, Chemistry, Process & Analytical Development

  • Advanced synthesis technologies
  • Oligo delivery methods
    • Oral Delivery
    • Lipid nanoparticles delivery
    • Injected/subcutaneous delivery
  • Purification technology development:
    • Freeze-drying
    • Chromatography
  • Impurity analysis

Afternoon Session: Oligo & miRNA Therapeutics

  • Oligo therapeutics:
    • Oncology
    • Genetic disorders
    • Cardiovascular diseases
    • Rare diseases
    • Infectious diseases
  • miRNA therapeutics

Confirmed Speakers

The Symposium brings together a panel of prominent leaders, engineers and scientists sharing new case studies, innovative data and industry outlook for the future


Chandra Vargeese

Wave Life Sciences


Punit Seth

Ionis Pharmaceuticals

steve hood

Steve Hood


charles sinclair

Charles Sinclair

Bristol-Myers Squibb

michael keller

Michael Keller

F.Hoffman-La Roche Ltd
Andrew Livingstone

Andrew Livingston

Queen Mary University of London

Event Features​

Networking and knowledge Sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of virtual, remote experiences. 

Virtual Presentations

Benefit from the insight of our expert speakers via live and pre-recorded presentations

Live Q&As

Interact with fellow attendees and speakers during the live Q&As at the end of each presentation

Digital Networking Opportunities

Connect directly with other registrants of event around the world